Riskpilot← Back to searchSign inGet full accessXerxes Faez AB
ABActiveOrg 5568114622Järnvägsgatan 8 BvDental practice care activities · NACE 8623Est. 20105 employees
Revenue 2025
SEK 6,1M
+13% vs 2024
EBITDA margin
13.8%
+35% vs 2024
Equity ratio
75.6%
Financial strength
Net profit 2025
SEK 286K
-58% vs 2024
| Revenue | SEK 6,1M | +13% |
| EBITDA | SEK 849K | +35% |
| Net profit | SEK 286K | -58% |
| Total assets | SEK 7,9M | +0% |
| Equity | SEK 6M | -3% |
| Employees | 5 | — |
Legal name
Xerxes Faez AB
Org number
5568114622
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
14 juni 2010
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva tandläkarpraktik samt därmed förenlig verksamhet.
Address
Järnvägsgatan 8 Bv
Email
tandkliniken@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 886 | 5 876 | 6 479 | 5 426 | 6 141 |
| Staff expenses | — | −2 521 | −2 592 | −2 378 | −2 713 |
| EBITDA | 1 525 | 850 | 1 379 | 631 | 849 |
| Depreciation & amort. | −313 | −392 | −186 | −318 | −403 |
| EBIT | 1 212 | 458 | 1 193 | 312 | 446 |
| Net financials | −8 | −3 | 11 | 68 | 64 |
| Profit before tax | 1 165 | 455 | 1 256 | 874 | 372 |
| Tax | −256 | −97 | −272 | −198 | −85 |
| Net profit | 909 | 357 | 984 | 676 | 286 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 272 | 7 336 | 7 909 | 7 923 | 7 913 |
| Equity | 4 865 | 4 922 | 5 906 | 6 182 | 5 981 |
| Long-term debt | 101 | 30 | 0 | 353 | 119 |
| Short-term debt | 612 | 689 | 360 | 239 | 526 |
| Total debt | 713 | 719 | 360 | 591 | 645 |
EBITDA margin
13.8%
This company
15.8%
Market median
-13% vs market
20212025
Equity ratio
75.6%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20212025
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20212025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EE Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2023 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xerxes Faez AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Elisabeth Hansen | Chief Auditor | 0 companies |
| Norah O'Connor | Deputy Board Member | 0 companies |
| Golnoush Lundén | Deputy Board Member | 0 companies |
| Xerxes Fardid Faez | Board of Directors | 0 companies |